Clinitech Laboratory Limited
BSE: CTLLAB · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Clinitech Laboratory Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Clinitech Laboratory Limited is a Navi Mumbai-based healthcare provider specialising in diagnostic and pathological testing services. The company operates a central laboratory and a network of collection centres, offering over 150 different tests across disciplines such as biochemistry, haematology, and molecular biology.
Business Model
The company generates revenue by providing diagnostic solutions to individual patients, corporate clients, and healthcare institutions. It leverages its regional infrastructure in Thane and Mumbai to capture demand for preventive healthcare and diagnostic accuracy.
- Test Portfolio:150+ types
Growth Outlook
Growth is driven by the increasing regional demand for preventive healthcare and the company's focus on maintaining diagnostic accuracy. The firm aims to capitalise on its established presence within the Thane and Mumbai markets.
Key Risks
- Geographic Concentration. The company's operations are heavily concentrated in the Thane and Mumbai regions, making it vulnerable to local economic or regulatory shifts.
- Regulatory Compliance. Diagnostic laboratories are subject to stringent healthcare regulations and quality standards, where non-compliance could lead to operational suspension.
- Intense Competition. The healthcare diagnostic sector in India is highly fragmented and competitive, which may exert pressure on pricing and profit margins.
- Technological Obsolescence. Failure to continuously upgrade diagnostic equipment and adopt new testing methodologies could result in a loss of market share to more advanced competitors.
Start your research today
Unlock AI insights, financials, peers and live data on Clinitech Laboratory Limited and 5,000+ companies — free.
Peers · Healthcare Service Provider
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Clinitech Laboratory LimitedCTLLAB | ₹8 Cr | — | — | — | 10.4% | — | — | -30.3% |
Krsnaa Diagnostics Ltd.KRSNAA | ₹1,830 Cr | 18.76 | 8.80 | 10.2% | 32.5% | 10.5% | 13.3% | -28.5% |
Suraksha Diagnostic Ltd.SURAKSHA | ₹1,772 Cr | 48.60 | 16.73 | 22.5% | 32.7% | 15.8% | 18.6% | +14.0% |
3B BlackBio Dx Ltd3BBLACKBIO | ₹1,237 Cr | 20.61 | 14.59 | 41.9% | 58.0% | 21.2% | 26.3% | +0.5% |
One Global Service Provider LimitedONEGLOBAL | ₹1,068 Cr | — | — | — | 19.0% | — | — | +114.9% |
Gaudium IVF and Women Health LimitedGAUDIUMIVF | ₹886 Cr | — | — | — | 36.0% | — | — | — |
As of Mar 2026
Financials
Clinitech Laboratory Limited
BSE: CTLLAB · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Clinitech Laboratory Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Clinitech Laboratory Limited is a Navi Mumbai-based healthcare provider specialising in diagnostic and pathological testing services. The company operates a central laboratory and a network of collection centres, offering over 150 different tests across disciplines such as biochemistry, haematology, and molecular biology.
Business Model
The company generates revenue by providing diagnostic solutions to individual patients, corporate clients, and healthcare institutions. It leverages its regional infrastructure in Thane and Mumbai to capture demand for preventive healthcare and diagnostic accuracy.
- Test Portfolio:150+ types
Growth Outlook
Growth is driven by the increasing regional demand for preventive healthcare and the company's focus on maintaining diagnostic accuracy. The firm aims to capitalise on its established presence within the Thane and Mumbai markets.
Key Risks
- Geographic Concentration. The company's operations are heavily concentrated in the Thane and Mumbai regions, making it vulnerable to local economic or regulatory shifts.
- Regulatory Compliance. Diagnostic laboratories are subject to stringent healthcare regulations and quality standards, where non-compliance could lead to operational suspension.
- Intense Competition. The healthcare diagnostic sector in India is highly fragmented and competitive, which may exert pressure on pricing and profit margins.
- Technological Obsolescence. Failure to continuously upgrade diagnostic equipment and adopt new testing methodologies could result in a loss of market share to more advanced competitors.
Start your research today
Unlock AI insights, financials, peers and live data on Clinitech Laboratory Limited and 5,000+ companies — free.
Peers · Healthcare Service Provider
As of Mar 2026